Clinical Trial Update: Pharmacokinetics of Sugammadex for the Reversal of Moderate Neuromuscular Blockade in Patients During Renal Transplantation [Phase 4]

View source ↗

Summary

Phase 4 study investigating the pharmacokinetics of sugammadex used to reverse moderate neuromuscular blockade in patients undergoing renal transplantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Transplant Complications

Drugs mentioned

• Sugammadex (sugammadex)

Snippet

Sponsor: Guangzhou General Hospital of Guangzhou Military Command | Conditions: Pharmacokinetics | Phase 4 | Status: UNKNOWN